Drug Pipeline

15 drugs associated with Adenosine deaminase-deficient severe combined immunodeficiency

DrugPhaseSponsor
Cyclosporine

Cyclosporine is a calcineurin inhibitor that inhibits T cell activation. Its binding to the receptor cyclophilin-1 inside cells produces a complex known as cyclosporine-cyclophilin. This complex subsequently inhibits calcineurin, which in turn stops the dephosphorylation as well as the activation of the nuclear factor of activated T cells (NF-AT) that normally cause inflammatory reactions. NF-AT is a transcription factor that promotes the production of cytokines such as IL-2, IL-4, interferon-g

Phase 1Fred Hutchinson Cancer Center
Lentiviral Gene Transfer
Phase 1National Human Genome Research Institute (NHGRI)
Mycophenolate Mofetil

The active metabolite of mycophenolate, mycophenolic acid, prevents T-cell and B-cell proliferation and the production of cytotoxic T-cells and antibodies. Lymphocyte and monocyte adhesion to endothelial cells of blood vessels that normally part of inflammation is prevented via the glycosylation of cell adhesion molecules by MPA. MPA inhibits de novo purine biosynthesis (that promotes immune cell proliferation) by inhibiting inosine 5’-monophosphate dehydrogenase enzyme (IMPDH), with a preferent

Phase 1Fred Hutchinson Cancer Center
pivotal
phase1_2
ADA gene transfer
Phase 2Donald B. Kohn, M.D.
Busulfan

Busulfan is an alkylating agent that contains 2 labile methanesulfonate groups attached to opposite ends of a 4-carbon alkyl chain. Once busulfan is hydrolyzed, the methanesulfonate groups are released and carbonium ions are produced. These carbonium ions alkylate DNA, which results in the interference of DNA replication and RNA transcription, ultimately leading to the disruption of nucleic acid function. Specifically, its mechanism of action through alkylation produces guanine-adenine intrastra

Phase 2Fondazione Telethon
Gene Therapy
Phase 2Fondazione Telethon
PEG-ADA ERT
Phase 2University of California, Los Angeles
Adagen

2'-deoxyadenosine hydrolytic enzyme; Adenosine hydrolytic enzyme

Phase 3Leadiant Biosciences, Inc.
EZN-2279

The ADA-SCID is caused by the presence of mutations in the ADA gene which is responsible for the synthesis of adenosine deaminase. This enzyme is found throughout the body but it is mainly active in lymphocytes. The normal function of adenosine deaminase is to eliminate deoxyadenosine, created when DNA is degraded, by converting it into deoxyinosine. This degradation process is very important as deoxyadenosine is cytotoxic, especially for lymphocytes. Immature lymphocytes are particularly vulner

Phase 3Leadiant Biosciences, Inc.
approaches remain
Preclinical
ADA PBSC
unknownNational Human Genome Research Institute (NHGRI)
elapegademase-lvlr

The ADA-SCID is caused by the presence of mutations in the ADA gene which is responsible for the synthesis of adenosine deaminase. This enzyme is found throughout the body but it is mainly active in lymphocytes. The normal function of adenosine deaminase is to eliminate deoxyadenosine, created when DNA is degraded, by converting it into deoxyinosine. This degradation process is very important as deoxyadenosine is cytotoxic, especially for lymphocytes. Immature lymphocytes are particularly vulner

unknownChiesi Farmaceutici S.p.A.
Strimvelis

ADA exogenous gene

unknownFondazione Telethon
Transduced Lymphocytes

ADA exogenous gene

unknownNational Human Genome Research Institute (NHGRI)